Return to Article Details FIRST-LINE TREATMENT WITH PEMBROLIZUMAB PLUS CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER WITHOUT TUMOR PD-L1 EXPRESSION Download Download PDF